JHS Svendgaard Laboratories Ltd

Stage 3 · Topping · week 1

As of 20 Nov 2026, JHS Svendgaard Laboratories is in Stage 3, the topping phase, now in its first week (since 17 Nov 2026). It closed at ₹7.93, 36.3% below its 52-week high and below its 200-day average, which is falling. In Consumer Staples, 12.3% of stocks are in Stage 2.

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. More about the company

₹7.9
Close, 20 Nov 2026
-0.88% on the day
₹69 Cr · Micro cap
Market DowntrendConsumer Staples 12.3% in Stage 2-20.7 pts / 20dFMCG - Personal Products 18.2%-9.1 pts

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

RS rank

Edge

—

JHS's uptrend is tiring: in its first week into a top. A topping stock either breaks back out or rolls over into a decline, and the next few weeks usually settle which.

Its relative strength is 23 of 99, below the middle among NSE stocks over the past year. FMCG - Personal Products ranks 34 of 106 industries by the strength of its stocks, among the leaders.

Is JHS early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2023-08-24 → 2026-11-20
S4 20w
S4 16w
S4 26w
2023-08-242026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 10w → S3 5w → S2 13w → S3 5w → S4 9w → S1 12w → S2 10w → S3 8w → S4 20w → S1 6w → S4 16w → S1 6w → S4 26w → S1 3w → S4 9w → S1 6w → S2 4w → S3 1w current
Total tracked: 169 weeks across 18 stage runs.

JHS among FMCG - Personal Products10th of 11 by relative strength

All 11 →
Stocks in FMCG - Personal Products ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CUPIDStage 2 · wk 3099+7.3%
2HONASAStage 3 · wk 494+19.1%
3BAJAJCONStage 4 · wk 290−4.9%
4MARICOStage 2 · wk 183+18.2%
5GILLETTEStage 4 · wk 3248−2.2%
6EMAMILTDStage 4 · wk 1144+11.9%
7GODREJCPStage 4 · wk 1343+7.0%
8COLPALStage 4 · wk 1842+2.3%
…10JHSStage 3 · wk 123−14.8%
vs 52W High
-36.3%
₹6.6 lo₹12.5 hi
36.3% below 52W high, weakening from peak
The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.
Stage Maturity
Week 1
1w13w26w
Week 1, early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-7.8%
200 DMA: ₹8.6 · sloping down
The stock has lost its 200-day average. In a topping stock that adds to the Stage 4 risk.
Rel Volume
0.12x
vs 50-day avg
Volume was well below average. Quiet sessions say little in a topping stock. Volume on the down days matters more.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-14.8%
3M
-5.7%
6M
-7.3%
YTD
-19.2%
1Y
-31.8%
Sector
Consumer Staples
↓ Peaking
Stage 2%
12.3%
20d Δ
-20.7pp
1M return
+8.4%
3M return
-0.1%
Sector Stage-2 % · last 20 days
Sector has 20 Stage 2 leaders. See Consumer Staples Stage 2 →
Industry
FMCG - Personal Products
↓ Peaking
Stage 2%
18.2%
20d Δ
-9.1pp
1M return
+8.3%
3M return
+2.2%
Industry Stage-2 % · last 20 days
Industry has 2 Stage 2 leaders. See FMCG - Personal Products Stage 2 →
Scan Membership
Not in any scan now.
Last appeared 19 Oct 2026
Recent Stage Timeline
2026-11-20S3
Wk 1 · Vol 0.12x
2026-11-19S3
Wk 1 · Vol 0.03x
2026-11-18S3
Wk 1 · Vol 0.06x
2026-11-17S32→3
Wk 1 · Vol 0.03x
2026-11-16S2
Wk 4 · Vol 0.05x
2026-11-13S2
Wk 4 · Vol 0.14x
2026-11-12S2
Wk 4 · Vol 0.08x
2026-11-11S2
Wk 4 · Vol 0.13x
2026-11-09S2
Wk 3 · Vol 0.10x
2026-11-06S2
Wk 3 · Vol 0.15x
2026-11-05S2
Wk 3 · Vol 0.15x
2026-11-04S2
Wk 3 · Vol 0.29x
Moving averages & range
50 DMA
₹8.7
200 DMA
₹8.6
52W High
₹12.5
52W Low
₹6.6
5D Low
₹7.9
Resistance levels (recent highs)
20d High
₹8.4
60d High
₹12.5
120d High
₹12.5
250d High
₹12.5
Next resistance
+6.1%
to 20d High
Earnings Growth (YoY)
0.0%
Revenue +24.6%
ROE
-1.1%
Profit margin -1.7%
Dividend Yield
0.00%
P/B 0.4

JHS Svendgaard Laboratories: quick answers

What stage is JHS Svendgaard Laboratories in?

As of 20 Nov 2026, JHS Svendgaard Laboratories (JHS) is in Stage 3, the topping phase. It entered Stage 3 on 17 Nov 2026 and is in its first week there. What the four stages mean

Is JHS Svendgaard Laboratories in an uptrend?

Its uptrend has stalled. JHS Svendgaard Laboratories is in Stage 3, the topping phase that follows an advance. It trades 7.8% below its 200-day average, which is falling.

How far is JHS Svendgaard Laboratories from its 52-week high?

JHS Svendgaard Laboratories closed at ₹7.93 on 20 Nov 2026, 36.3% below its 52-week high of ₹12.45. Its 52-week low is ₹6.55.

How has JHS Svendgaard Laboratories performed over the past year?

As of 20 Nov 2026, JHS Svendgaard Laboratories is down 31.8% over the past year and down 19.2% so far in 2026.

Which sector and industry is JHS Svendgaard Laboratories in?

JHS Svendgaard Laboratories is in the FMCG - Personal Products industry, part of the Consumer Staples sector. 21 stocks in Consumer Staples are in Stage 2, 12.3% of the sector. See the Stage 2 stocks in Consumer Staples

About this companyConsumer Staples· FMCG - Personal Products

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products. In addition, the company exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.